A--Resource for the Collection of Human Tissues, Cells, Biofluids and Epidemiologi
ID: 75N91024R00018Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNIH NCIBethesda, MD, 20892, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH (AN11)

Original Source

https://sam.gov/opp/bc5f026ddf134349a986288c429516de/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) National Cancer Institute (NCI), is seeking capability statements from organizations for a contract focused on the collection and evaluation of human tissues, cells, and biofluids from donors with epidemiologic profiles. This initiative aims to support molecular epidemiology studies related to various cancers, including lung, breast, liver, and pancreatic cancer, and involves tasks such as participant recruitment, biological specimen collection, and data processing while ensuring compliance with ethical regulations. The contract, anticipated to last five years, builds on efforts initiated in 1996 and emphasizes the importance of delivering viable tissues promptly and maintaining data confidentiality. Interested organizations, excluding the current provider, must submit their qualifications by February 18, 2025, and can contact Whitney D. Monkama at whitney.monkam@nih.gov or +1 240 276 5446 for further information.

    Point(s) of Contact
    MONKAM, WHITNEY D
    +1 240 276 5446
    whitney.monkam@nih.gov
    Files
    Title
    Posted
    Sources_Sought-_Final_1.docx
    Sources Sought- Final.pdf
    The National Cancer Institute (NCI) is seeking capability statements from organizations regarding a contract for the collection and evaluation of human tissues, cells, and bio-fluids from donors with an epidemiologic profile. This initiative, managed by the Laboratory of Human Carcinogenesis, is intended to support molecular epidemiology studies focused on various cancers, including lung, breast, liver, and pancreatic cancer. The contractor will be tasked with recruiting participants, collecting biological specimens, processing epidemiological data, and ensuring compliance with ethical regulations. The contract aims to continue and enhance previous efforts that started in 1996, shifting from tissue collection for experimental development to comprehensive case-control studies. Eligible organizations should respond by outlining their ability to meet the project's requirements, which include delivering viable tissues within three hours and maintaining data confidentiality. The anticipated contract period is five years, with considerations for small business set-asides. The notice encourages potential applicants, excluding the current provider, to demonstrate their qualifications and capabilities by submitting statements by February 18, 2025.
    SOW_DRAFT 01.15.25.pdf
    The draft Statement of Work outlines the objectives and tasks for a contractor supporting the Laboratory of Human Carcinogenesis (LHC) in researching the molecular epidemiology of human cancer. Key responsibilities include recruiting cancer cases and population-based controls, collecting and processing biological specimens, and maintaining ethical and legal approvals. The contractor is expected to accrue targeted cancer case numbers annually, covering various types including lung, liver, and pancreatic cancers, while also gathering demographic and medical data through structured questionnaires. Biological samples must be handled and stored per regulatory standards, with regular reporting and data management requirements. The document emphasizes compliance with the Privacy Act and health regulations, as well as ensuring accessibility under Section 508 standards. Transition plans for phase-in and phase-out of contract activities, alongside extensive training requirements for personnel interacting with patients, are also detailed. Overall, this work underlines a significant commitment to advancing cancer research through meticulous data collection and specimen management.
    Lifecycle
    Title
    Type
    A--Resource for the Collection of Human Tissues, Cells, Biofluids and Epidemiologi
    Currently viewing
    Sources Sought
    Similar Opportunities
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Buyer not available
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    DNA Extractor
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of a DNA Extractor, specifically the Promega DNA Extractor or an equivalent model. This acquisition aims to enhance laboratory capabilities for research on neurodegenerative diseases, particularly by automating the purification of nucleic acids from various biological samples, which is critical for advancing scientific research in this field. Interested vendors must submit their quotations by March 24, 2025, at 12:00 PM Eastern Time, and should direct their proposals to Andrea Clay at amcgee@nida.nih.gov. The anticipated delivery date for the equipment is 30 days after receipt of the order, with the contract expected to be awarded as a firm fixed-price purchase order.
    75N93025R00013 - Medical Residents for NIH's Clinical Center
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for the provision of Medical Residents at its Clinical Center in Bethesda, Maryland. The contract, structured as a Multiple Award Indefinite Quantity contract, aims to enhance clinical care for adult and pediatric inpatients involved in NIH research, requiring contractors to supply up to four postgraduate medical residents daily for a minimum of 80 hours per week. Proposals must be submitted by April 14, 2025, with a total funding range between $2,000 and $7,500,000 over the performance period from May 31, 2025, to May 30, 2030. Interested parties should direct inquiries to Sevag Kasparian or Maya Joseph via their provided emails for further clarification on the solicitation documents.
    Acquisition of Support Services of an MRI Physicist
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole-source contract for the acquisition of support services from an MRI physicist, with a focus on early detection of non-alcoholic steatohepatitis (NASH) and metabolic-associated steatohepatitis (MASH). The contractor will be responsible for identifying non-invasive MRI biomarkers for hepatic inflammation and developing imaging techniques, requiring a PhD and over 15 years of relevant experience in MRI data acquisition and pulse sequence programming. This initiative is critical for addressing diagnostic gaps in differentiating NASH/MASH from benign liver conditions, ultimately aiming to enhance patient outcomes through advanced MRI methodologies. Interested parties may contact Amber Harris at amber.harris@nih.gov, with the contract valued at up to $250,000 and scheduled to span from March 30, 2025, to March 29, 2026.
    Notice of Intent-Specialized Acupuncture Services for the Pain and Palliative Care Services Department
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure specialized acupuncture services for its Pain and Palliative Care Services Department. The selected contractor will provide acupuncture support aimed at enhancing the quality of life for patients involved in clinical research, with a contract period from April 1, 2025, to March 31, 2026, and four additional option periods. This initiative underscores the importance of integrating alternative therapies into clinical care, particularly for patients with advanced illnesses undergoing experimental treatments. Interested parties must submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by March 24, 2025, with the total contract value not exceeding $250,000.
    MAINTENANCE AGREEMENT ON BC T100 PROCESSING UNIT
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through its National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract for a 12-month maintenance agreement on a BC T200 Processing Unit with Global Life Sciences Solutions USA LLC. The procurement requires comprehensive service, including two planned preventive maintenance visits, priority response for repairs, and access to certified service engineers, ensuring the equipment operates effectively in a multi-user environment reliant on precise results. Interested vendors capable of meeting these requirements must submit a capability statement by 10:00 AM EST on March 20, 2025, via the NIAID electronic Simplified Acquisition Submission System (eSASS), with all necessary documentation and manufacturer certification included. For further inquiries, vendors may contact Mildred Moss at mildred.moss@nih.gov or Tonia Alexander at talexander@niaid.nih.gov.
    The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for the Liver Cirrhosis Network
    Buyer not available
    Special Notice HEALTH AND HUMAN SERVICES, DEPARTMENT OF seeks industry partners for clinical research collaborations on therapeutics, diagnostics or devices for the Liver Cirrhosis Network. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is looking for industry collaborators to provide novel or repurposed therapeutic agents, diagnostic markers, biomarkers, devices, or services for use in NIH-sponsored multi-center clinical trials and ancillary studies in adult patients with advanced liver disease and cirrhosis. The Liver Cirrhosis Network aims to promote clinical and translational research on cirrhosis of the liver and related complications in adults. The network is interested in conducting research that will lead to improved clinical outcomes in adults with cirrhosis and advanced liver disease. Commercial organizations interested in pursuing clinical collaborations with NIDDK for cirrhosis liver disease are required to submit a Capability Statement to the NIDDK.
    Acquisition of a Service Contract for Thermo Lumos Mass Spectrometer
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a non-competitive service contract for the maintenance of a Thermo Lumos Mass Spectrometer. This procurement, classified under NAICS code 811210, aims to ensure uninterrupted analytical support for the National Institute of Digestive, Diabetes & Kidney Diseases (NIDDK) research, as the complexity of the spectrometer requires specialized technicians from Thermo Electron North America LLC. The contract will be effective for three years and includes key tasks such as emergency technical support and scheduled preventive maintenance. Interested parties may respond with their capabilities by the deadline of March 24, 2024, although this announcement is not a request for competitive proposals. For further inquiries, contact Amber Harris at amber.harris@nih.gov.
    10X Genomics, Inc Chromium instrument.
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure a 10X Genomics, Inc Chromium instrument on a sole source basis for its Clinical Center's Department of Laboratory Medicine. This procurement includes a Chromium X and accessory kit, dual index kits, GEM-X Flex gene expression chip kits, and other related items essential for conducting single-cell gene expression experiments using patient-derived samples. The 10X Genomics Chromium instrument is critical for analyzing mRNA levels at the single-cell level, and its use is validated for quality-controlled processes within the NIH. Interested parties capable of providing similar products must submit a capability statement by March 22, 2025, to Emeka Onyejekwe at emeka.onyejekwe@nih.gov for consideration.
    Renewal Maintenance Service Agreement for Becton Dickinson (BD) Flow Cytometers
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking a contractor to provide a Renewal Maintenance Service Agreement for Becton Dickinson (BD) flow cytometers, which are critical for the Laboratory of Immune System Biology's research on immune function and pathogen response. The agreement includes essential services such as two preventive maintenance inspections, unlimited service visits by original equipment manufacturer (OEM) technicians, and 48-hour emergency support, all adhering to Biosafety Level 2 standards. This maintenance is vital for ensuring the operational integrity of high-end flow cytometry systems used in daily experiments, thereby supporting ongoing immunology research. The period of performance for this contract is from April 1, 2024, to March 31, 2025, and interested parties can contact Linda Smith at linda.smith2@nih.gov or Kathy Song at kathy.song@nih.gov for further information.